8. Byetta - Top 10 Drug Warnings and Recalls

Drug: Byetta

2006 sales: $430 million

Manufacturer: Amylin

Safety concern: Precautionary language , pancreatitis

Related Articles:
> Lilly diabetes med linked to pancreatitis. Report
> Amylin shares shoot up on Phase II Byetta results. Report

8. Byetta - Top 10 Drug Warnings and Recalls

Suggested Articles

Several of the industry's top players had a strong performance in the fourth quarter, growing revenues at high single digits. Others? Not so much.

Viatris, the merger of Mylan and Pfizer's Upjohn, has fleshed out its board and C-suite with a raft of Pfizer and Mylan veterans.

An FDA approval of Lilly’s Cyramza combo would pit it against AZ's Tagrisso, which has charted impressive survival gains in EGFR-positive lung cancer.